G. L. A. de Oliveira, “Incorporated antivirals for chronic hepatitis B in Brazil: a cost-effectiveness analysis”, Rev. saúde pública, vol. 47, no. 4, pp. 769–780, Aug. 2013, doi: 10.1590/rsp.v47i4.76609.